Béatrice Pallot-Pradès

Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

Benjamin Terrier, Zahir Amoura, Philippe Ravaud et al. · Arthritis & Rheumatism · 2010 · 410 citations

Life Sciences, Immunology, Pharmacotherapy +13

A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab

Hubert Marotte, Béatrice Pallot-Pradès, Laurent Grange et al. · Arthritis Research & Therapy · 2007 · 123 citations · Full text

Medicine, Pharmacotherapy, Bone Metabolism +16

Exposition to anti-TNF drugs during pregnancy: Outcome of 15 cases and review of the literature

Jean‐Marie Berthelot, Michel De Bandt, Philippe Goupille et al. · Joint Bone Spine · 2008 · 116 citations

Medicine, Immunology, Obstetrics +11

Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: Six years of case-referent surveillance

Lamiae Grimaldi‐Bensouda, Michel Rossignol, Isabelle Kone‐Paut et al. · Journal of Autoimmunity · 2017 · 84 citations · Full text

Medicine, Immunology, Pediatrics +15

Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis

Candice Trocmé, Hubert Marotte, Athan Baillet et al. · Annals of the Rheumatic Diseases · 2008 · 80 citations · Full text

Life Sciences, Immunology, Pharmacology +17